Lactational mastitis
Conditions
Interventions
Experimental group:The ultrasonic drug - delivery function of the Shengnuo Multifunctional Physiotherapy Instrument (Model SN - 2211T) was used for treatment. The drug for delivery was Furong Liquid,
Control group:Assist the patient to assume a supine or sitting position, fully expose the breast, ensure warmth, let the breast hang naturally and loosely, and have the patient relax completely. Use a
Sponsors
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Eligibility
Sex/Gender
All
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for acute mastitis in lactation; (2) no pus after ultrasound examination; (3) the course of the disease is within 7 days; (4) No systematic and standardized treatment since the onset of the disease; (5) Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those who are allergic to adhesive tape and other external stickers; (2) Body temperature > 38.5°C; (3) Breast cancer patients; (4) Plasma cell mastitis or granulomatous lobular mastitis (lactating or non-lactating); (5) Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system; (6) Patients with severe skin diseases, diabetes and mental illness; (7) Those who have received other related treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The area of breast masses;VAS (Visual Analogue Scale) Score for Breast Pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| The resolution proportion of breast masses;The reduction proportion of breast masses;The area of redness and swelling;The patency of breast milk; | — |
Countries
China
Contacts
Public ContactZhang Dongxiao
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Outcome results
None listed